A business in context

BDSX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-12 · 0000905148-26-003641

  2. 4 · Ownership change

    Report date 2026-08-10 · 0000905148-26-003599

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-335036

  4. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-335010 · Items 2.02,9.01

  5. 4 · Ownership change

    Report date 2026-06-30 · 0000905148-26-003146

  6. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-232631 · Items 5.07,9.01

  7. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-203960

  8. 8-K · Current report

    Report date 2026-05-04 · 0001193125-26-203936 · Items 2.02,9.01

  9. DEF 14A · Proxy statement

    Report date 2026-05-19 · 0001193125-26-149633

  10. 4 · Ownership change

    Report date 2026-03-31 · 0000905148-26-001495

  11. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076547

  12. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-076521 · Items 2.02,9.01

  13. 4 · Ownership change

    Report date 2026-02-20 · 0000905148-26-000990

  14. 4 · Ownership change

    Report date 2026-02-20 · 0000905148-26-000989

  15. 4 · Ownership change

    Report date 2026-02-20 · 0000905148-26-000988

  16. 4 · Ownership change

    Report date 2026-02-20 · 0000905148-26-000987

  17. 8-K/A · Current report

    Report date 2026-01-12 · 0001193125-26-010114 · Items 2.02,9.01

  18. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-262532

  19. 8-K · Current report

    Report date 2025-11-03 · 0001193125-25-262508 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2025-09-26 · 0001193125-25-226749 · Items 8.01

  21. 8-K · Current report

    Report date 2025-09-12 · 0001193125-25-203746 · Items 3.03,5.03,9.01

  22. 8-K · Current report

    Report date 2025-09-11 · 0001193125-25-200766 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-08-07 · 0001439725-25-000003 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105026

  25. 8-K · Current report

    Report date 2025-05-20 · 0001193125-25-124047 · Items 5.07,9.01

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-070339

  27. 8-K · Current report

    Report date 2025-05-13 · 0000950170-25-070292 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-05-20 · 0001193125-25-100458

  29. 8-K · Current report

    Report date 2025-04-15 · 0001193125-25-084319 · Items 5.02

  30. 8-K · Current report

    Report date 2025-03-24 · 0000950170-25-046748 · Items 3.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-030835

  32. 8-K · Current report

    Report date 2025-03-03 · 0000950170-25-030814 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-01-10 · 0000950170-25-003717 · Items 2.02,9.01

  34. SC 13G/A · Ownership disclosure

    0001493152-24-044966

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-119792

  36. 8-K · Current report

    Report date 2024-11-01 · 0000950170-24-119791 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-08-14 · 0001193125-24-200857 · Items 7.01,9.01

  38. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-092773

  39. 8-K · Current report

    Report date 2024-08-07 · 0000950170-24-092722 · Items 2.02,9.01

  40. SC 13G · Ownership disclosure

    0000898432-24-000508

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

2 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-03-31
2026-04-02
PATIENCE JOHNM · Exercise / conversion
Acquired
Common Stock1361.0
2026-03-31
2026-04-02
PATIENCE JOHNM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
1361.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001439725BIODESIX INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$71.32M$75.92M
    2023-12-31$49.09M$53.79M
    2022-12-31$38.21M$43.59M
    2021-12-31$54.51M$67.16M
    2020-12-31$45.56M$58.78M
    2019-12-31$24.55M$32.07M

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗